Protocol No. FTY720D2312, entitled #A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once

  • Slevin, John (PI)
  • Dobbs, Michael (Former PI)
  • Kedar, Sachin (Former PI)
  • Berger, Joseph (Former CoI)

Grants and Contracts Details

Effective start/end date3/1/122/28/16


  • Novartis (domestic): $3,350.00